TRESSA CRAMER: Open Payments
NPI 1619519238 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 20 payments from 8 companies in 2025. Trend: 2023 $398 · 2024 $510 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Exact Sciences Corporation | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: Rybelsus, AIRSUPRA, Wegovy, The Cologuard Plus Collection Kit, ZORYVE, Dexcom G6 Transmitter, ROTATEQ, MOUNJARO.
Industry payments across TX — which companies pay providers there.
